A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
Clinical trial NCT04814368 · TERMINATED
Trial details
- NCT number
- NCT04814368
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-27
- Primary completion
- 2024-06-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.